Amplia Therapeutics Limited Stock
Stocks
ATX
AU0000023822
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Australian S.E.
02:10:26 2026-09-18 am EDT
|
5-day change | 1st Jan Change | ||
| 0.1250 AUD | 0.00% |
|
+4.17% | -16.67% |
| Market Cap | 64.16M 45.61M 39.77M 37.56M 34.1M 63.9M 4.38B 450M 174M 2.23B 171M 168M 7.16B | P/E 2027 * |
-5.43x | P/E 2028 * | -17.9x |
|---|---|---|---|---|---|
| Enterprise Value | 46.26M 32.89M 28.68M 27.08M 24.59M 46.07M 3.16B 324M 125M 1.6B 124M 121M 5.16B | EV / Sales 2027 * |
-
| EV / Sales 2028 * | 4.29x |
| Free-Float |
90.48% | Yield 2027 * |
-
| Yield 2028 * | - |
Australian S.E.AUD
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| ATX | Delayed | |
OTC Markets
| INNMF | Delayed |
| 1 week | +4.17% | ||
| Current month | -7.41% | ||
| 1 month | -19.35% | ||
| 3 months | +4.17% | ||
| 6 months | +11.11% | ||
| Current year | -16.67% |
| 1 week | 0.12 |  | 0.14 |
| 1 month | 0.12 | | 0.16 |
| Current year | 0.1 | | 0.28 |
| 1 year | 0.1 | | 0.28 |
| 3 years | 0.05 | | 0.42 |
| 5 years | 0.05 | | 0.42 |
| 10 years | 0.04 | | 18.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2022-12-04 | |
Hamish George
DFI | Director of Finance/CFO | - | 2021-09-30 |
Jason Lickliter
CTO | Chief Tech/Sci/R&D Officer | - | 2025-05-11 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Peach
BRD | Director/Board Member | 70 | 2015-09-01 |
Warwick Tong
CHM | Chairman | - | 2018-05-24 |
Jane Bell
CHM | Chairman | - | 2026-06-29 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/8/25 | Exercice | Chairman | 750,000 | 0.1933% | ||
| 9/8/25 | Free | Founder | 447,000 | 0.1152% | ||
| 9/8/25 | Exercice | Director | 535,000 | 0.1379% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | +4.17% | -19.35% | +48.81% | 45.61M | |
| -0.31% | +5.79% | +48.93% | +97.53% | 70.88B | |
| +0.39% | +2.06% | +40.91% | +78.49% | 62.49B | |
| -3.21% | -7.27% | -17.73% | +351.98% | 26.21B | |
| +0.50% | +7.13% | +29.43% | +15.48% | 26.34B | |
| -2.64% | -0.69% | -0.26% | -11.90% | 24.13B | |
| +0.71% | +8.03% | +27.22% | -13.18% | 20.72B | |
| -1.26% | -7.81% | +169.33% | +302.38% | 15.36B | |
| -0.22% | +3.99% | +44.28% | +173.35% | 14.46B | |
| +0.73% | +1.71% | -7.18% | +886.19% | 14.25B | |
| Average | -0.53% | +1.90% | +31.56% | +192.91% | 27.49B | |
| Weighted average by Cap. | -0.47% | +1.44% | +36.50% | +147.96% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | - | 9.5M 6.75M 5.89M 5.56M 5.05M 9.46M 648M 66.61M 25.7M 329M 25.37M 24.81M 1.06B |
| Net income | -11.6M -8.25M -7.19M -6.79M -6.17M -11.55M -791M -81.33M -31.39M -402M -30.98M -30.29M -1.29B | -4.1M -2.91M -2.54M -2.4M -2.18M -4.08M -280M -28.75M -11.09M -142M -10.95M -10.71M -458M |
| Net Debt | -17.9M -12.72M -11.1M -10.48M -9.51M -17.83M -1.22B -126M -48.43M -621M -47.8M -46.74M -2B | -23.4M -16.63M -14.51M -13.7M -12.44M -23.3M -1.6B -164M -63.31M -812M -62.49M -61.1M -2.61B |
Employees
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-18 | A$0.1250 | 0.00% | 530,052 |
| 26-09-17 | A$0.1250 | +4.17% | 78,492 |
| 26-09-16 | A$0.1200 | 0.00% | 149,897 |
| 26-09-15 | A$0.1200 | 0.00% | 553,722 |
| 26-09-14 | A$0.1200 | 0.00% | 249,146 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.1250AUD
Average target price
0.4200AUD
Spread / Average Target
+236.00%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ATX Stock
Select your edition
All financial news and data tailored to specific country editions
